Calvas Oscar Israel Jaramillo, Ramos Daniel Marin, Matos Leandro Luongo, Kulcsar Marco Aurélio Vamondes, Dedivitis Rogério Aparecido, Brandão Lenine Garcia, Cernea Claudio Roberto
Division of Head and Neck Surgery, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Instituto do Câncer do Estado de São Paulo, São Paulo, SP, Brazil.
Rev Assoc Med Bras (1992). 2017 Dec;63(12):1082-1089. doi: 10.1590/1806-9282.63.12.1082.
Since the beginning of the 1990s, non-surgical radiochemotherapy treatment has become popular with the prospect of maintaining oncological results and preserving the organ in patients with advanced squamous cell carcinoma of the larynx and hypopharynx. However, subsequent studies demonstrated increased recurrence and mortality after the non-surgical treatment became popular.
To compare the oncological results of surgical and non-surgical treatments of patients with larynx and hypopharynx cancer and to evaluate the variables associated with disease recurrence.
This is a retrospective cohort study of 134 patients undergoing surgical (total or partial laryngectomy) or non-surgical (isolated radiotherapy, chemotherapy or induction chemotherapy followed by radiotherapy and chemotherapy) treatment, with 62 patients in the surgical group and 72 in the non-surgical group.
Disease-free survival rates were higher in the surgical group (81.7% vs. 62.2%; p=0.028), especially in III/IV stages (p=0.018), locally advanced tumors T3 and T4a (p=0.021) and N0/N1 cases (p=0.005). The presence of cervical lymph nodes, especially N2/N3, was considered a risk factor for disease recurrence in both groups (HR=11.82; 95CI 3.42-40.88; p<0.0001). Patients not undergoing surgical treatment were 3.8 times more likely to develop recurrence (HR=3.76; 95CI 1.27-11.14; p=0.039).
Patients with larynx or hypopharynx cancer non-surgically treated had a poorer disease-free survival, especially in cases with locally advanced tumors (T3 and T4a) and in which the neck was only slightly affected (N0/N1).
自20世纪90年代初以来,非手术放化疗治疗因有望在晚期喉和下咽鳞状细胞癌患者中维持肿瘤学疗效并保留器官而受到欢迎。然而,随后的研究表明,非手术治疗流行后复发率和死亡率有所增加。
比较喉癌和下咽癌患者手术和非手术治疗的肿瘤学疗效,并评估与疾病复发相关的变量。
这是一项回顾性队列研究,对134例接受手术(全喉或部分喉切除术)或非手术(单纯放疗、化疗或诱导化疗后再行放疗和化疗)治疗的患者进行研究,手术组62例,非手术组72例。
手术组的无病生存率更高(81.7%对62.2%;p=0.028),尤其是在III/IV期(p=0.018)、局部晚期肿瘤T3和T4a(p=0.021)以及N0/N1病例(p=0.005)中。两组中,颈部淋巴结的存在,尤其是N2/N3,被认为是疾病复发的危险因素(HR=11.82;95%CI 3.42-40.88;p<0.0001)。未接受手术治疗的患者复发可能性高3.8倍(HR=3.76;95%CI 1.27-11.14;p=0.039)。
接受非手术治疗的喉癌或下咽癌患者无病生存期较差,尤其是在局部晚期肿瘤(T3和T4a)且颈部仅轻微受累(N0/N1)的病例中。